Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
8
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Patel Snehal | CEO and CFO, Director, 10% Owner | 121 | $7.37M | $0 | 2026-07-29 |
| Hallock Kenneth | Director | 15 | $484.0K | $0 | 2024-12-24 |
| Rothe Eric | Director | 3 | $10.8K | $0 | 2024-12-24 |
| Daugherty Frank Joseph | Chief Medical Officer | 7 | $81.3K | $0 | 2024-12-24 |
| Thompson Jaye | VP Clinical Reg. Affairs | 23 | $164.8K | $0 | 2024-12-24 |
| McWilliams David | Director | 15 | $28.6K | $0 | 2024-12-24 |
| Patel Pankaj Amrit | 10% Owner | 3 | $0 | $0 | 2020-11-10 |
| Patel Kinnary | 10% Owner | 6 | $0 | $0 | 2020-09-29 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Patel Snehal | CEO and CFO | P Buy | 2026-07-29 | 2026-07-30 | 700 | $13.10 | $9.2K | 5,611,402 | SEC↗ |
| Patel Snehal | CEO and CFO, Director, 10% O | P Buy | 2026-07-29 | 2026-07-30 | 700 | $13.10 | $9.2K | 5,611,402 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2026-07-28 | 2026-07-30 | 1,500 | $13.59 | $20.4K | 5,610,702 | SEC↗ |
| Patel Snehal | CEO and CFO, Director, 10% O | P Buy | 2026-07-28 | 2026-07-30 | 1,500 | $13.59 | $20.4K | 5,610,702 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2026-07-27 | 2026-07-29 | 1,500 | $13.62 | $20.4K | 5,609,202 | SEC↗ |
| Patel Snehal | CEO and CFO, Director, 10% O | P Buy | 2026-07-27 | 2026-07-29 | 1,500 | $13.62 | $20.4K | 5,609,202 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2026-07-24 | 2026-07-27 | 1,100 | $12.88 | $14.2K | 5,607,702 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2026-07-23 | 2026-07-27 | 2,500 | $13.14 | $32.9K | 5,606,602 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2026-01-13 | 2026-01-15 | 1,800 | $29.83 | $53.7K | 5,604,102 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2026-01-12 | 2026-01-14 | 2,900 | $27.54 | $79.9K | 5,602,302 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2025-12-31 | 2026-01-05 | 4,300 | $21.36 | $91.8K | 5,599,402 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2025-12-30 | 2026-01-02 | 2,900 | $21.73 | $63.0K | 5,595,102 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2025-12-18 | 2025-12-19 | 4,100 | $12.62 | $51.7K | 5,592,202 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2025-11-25 | 2025-11-28 | 4,600 | $8.37 | $38.5K | 5,588,102 | SEC↗ |
| Patel Snehal | CEO and CFO | A Award deriv | 2025-11-13 | 2025-11-17 | 100,000 | — | $0 | 2,347,462 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2025-11-07 | 2025-11-12 | 10,600 | $8.43 | $89.4K | 5,583,502 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2025-10-31 | 2025-11-04 | 2,300 | $9.26 | $21.3K | 5,572,902 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2025-04-25 | 2025-04-29 | 3,600 | $9.88 | $35.6K | 5,570,602 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2025-04-17 | 2025-04-22 | 5,400 | $8.98 | $48.5K | 5,567,002 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2025-04-07 | 2025-04-08 | 3,600 | $9.10 | $32.8K | 5,561,602 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2025-04-04 | 2025-04-07 | 5,500 | $8.73 | $48.0K | 5,558,002 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2025-01-10 | 2025-01-13 | 2,500 | $12.51 | $31.3K | 5,552,502 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2025-01-07 | 2025-01-08 | 1,800 | $13.75 | $24.8K | 5,550,002 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2025-01-06 | 2025-01-08 | 1,100 | $13.31 | $14.6K | 5,548,202 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2025-01-03 | 2025-01-07 | 3,400 | $12.95 | $44.0K | 5,547,102 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2025-01-02 | 2025-01-06 | 2,000 | $11.97 | $23.9K | 5,543,702 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2024-12-31 | 2025-01-03 | 2,400 | $11.36 | $27.3K | 5,541,702 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2024-12-30 | 2025-01-02 | 3,200 | $11.12 | $35.6K | 5,539,302 | SEC↗ |
| Daugherty Frank Joseph | Chief Medical Officer | A Award deriv | 2024-12-24 | 2024-12-27 | 104,890 | — | $0 | 209,780 | SEC↗ |
| Rothe Eric | Director | A Award deriv | 2024-12-24 | 2024-12-27 | 41,349 | — | $0 | 82,698 | SEC↗ |
| Patel Snehal | CEO and CFO | A Award deriv | 2024-12-24 | 2024-12-27 | 1,148,723 | — | $0 | 2,222,454 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | A Award deriv | 2024-12-24 | 2024-12-27 | 149,818 | — | $0 | 299,636 | SEC↗ |
| Hallock Kenneth | Director | A Award deriv | 2024-12-24 | 2024-12-27 | 41,349 | — | $0 | 82,698 | SEC↗ |
| McWilliams David | Director | A Award deriv | 2024-12-24 | 2024-12-27 | 61,984 | — | $0 | 123,968 | SEC↗ |
| Patel Snehal | CEO and CFO | A Award deriv | 2024-12-24 | 2024-12-27 | 25,008 | — | $0 | 2,247,462 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2024-11-21 | 2024-11-25 | 1,000 | $12.91 | $12.9K | 264,148 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2024-09-26 | 2024-09-30 | 1,500 | $14.63 | $21.9K | 5,536,102 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2024-08-12 | 2024-09-16 | 800 | $13.85 | $11.1K | 263,148 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2024-08-06 | 2024-08-08 | 2,000 | $13.81 | $27.6K | 5,534,602 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2024-08-05 | 2024-08-07 | 5,500 | $13.18 | $72.5K | 5,532,602 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2024-08-02 | 2024-08-05 | 1,000 | $15.15 | $15.2K | 262,348 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2024-07-23 | 2024-07-24 | 1,500 | $15.89 | $23.8K | 5,527,102 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2024-07-18 | 2024-07-22 | 1,000 | $16.00 | $16.0K | 261,348 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2024-06-13 | 2024-06-17 | 174,825 | $14.30 | $2.50M | 5,525,602 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2024-04-01 | 2024-04-03 | 3,000 | $19.08 | $57.2K | 5,350,777 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2024-03-22 | 2024-03-26 | 2,500 | $19.98 | $50.0K | 5,347,777 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2024-03-20 | 2024-03-22 | 1,500 | $17.68 | $26.5K | 5,345,277 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2024-03-05 | 2024-03-07 | 30,500 | $12.49 | $380.9K | 5,343,777 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2024-03-05 | 2024-03-07 | 3,500 | $12.49 | $43.7K | 5,343,777 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2024-03-04 | 2024-03-06 | 4,100 | $13.03 | $53.4K | 5,340,277 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2024-02-16 | 2024-02-21 | 10,800 | $11.16 | $120.5K | 5,336,177 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2024-02-15 | 2024-02-20 | 12,700 | $11.07 | $140.6K | 5,325,377 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-11-10 | 2023-11-14 | 5,000 | $10.17 | $50.9K | 5,312,677 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-11-03 | 2023-11-07 | 3,500 | $9.11 | $31.9K | 5,307,677 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2023-10-27 | 2023-10-31 | 500 | $8.57 | $4.3K | 260,348 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-10-26 | 2023-10-30 | 2,500 | $7.97 | $19.9K | 5,304,177 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-10-25 | 2023-10-27 | 2,500 | $7.91 | $19.8K | 5,301,677 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-10-10 | 2023-10-12 | 1,000 | $9.07 | $9.1K | 5,299,177 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-10-04 | 2023-10-05 | 2,000 | $8.63 | $17.3K | 5,298,177 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2023-09-26 | 2023-09-28 | 600 | $8.71 | $5.2K | 259,848 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-09-19 | 2023-09-21 | 4,000 | $8.95 | $35.8K | 5,296,177 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-09-11 | 2023-09-13 | 1,000 | $9.48 | $9.5K | 5,292,177 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-08-22 | 2023-08-24 | 1,000 | $9.97 | $10.0K | 5,291,177 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-08-04 | 2023-08-08 | 2,000 | $10.55 | $21.1K | 5,290,177 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-07-21 | 2023-07-25 | 1,000 | $9.20 | $9.2K | 5,288,177 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2023-07-13 | 2023-07-17 | 250 | $9.49 | $2.4K | 259,248 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-05-17 | 2023-05-18 | 1,000 | $11.69 | $11.7K | 5,287,177 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2023-04-28 | 2023-05-02 | 250 | $11.22 | $2.8K | 258,998 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-04-19 | 2023-04-21 | 7,000 | $11.10 | $77.7K | 5,286,177 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-04-18 | 2023-04-20 | 2,000 | $11.12 | $22.2K | 5,279,177 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-04-11 | 2023-04-12 | 5,000 | $12.42 | $62.1K | 5,271,177 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2023-04-11 | 2023-04-12 | 1,000 | $11.87 | $11.9K | 258,745 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2023-03-15 | 2023-03-16 | 250 | $12.71 | $3.2K | 257,745 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-03-10 | 2023-03-13 | 1,000 | $12.12 | $12.1K | 2,737,486 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2023-02-24 | 2023-02-28 | 250 | $15.40 | $3.9K | 257,495 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-02-17 | 2023-02-22 | 600 | $16.53 | $9.9K | 2,736,486 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-02-10 | 2023-02-14 | 1,000 | $18.68 | $18.7K | 2,735,886 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2023-02-03 | 2023-02-07 | 250 | $20.84 | $5.2K | 257,245 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2023-01-27 | 2023-01-30 | 250 | $19.20 | $4.8K | 256,995 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-01-27 | 2023-01-31 | 2,000 | $19.35 | $38.7K | 2,734,886 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-01-20 | 2023-01-24 | 1,500 | $17.37 | $26.1K | 2,732,886 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2023-01-13 | 2023-01-17 | 250 | $16.50 | $4.1K | 256,745 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2023-01-06 | 2023-01-10 | 1,500 | $15.18 | $22.8K | 2,731,386 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-12-29 | 2023-01-03 | 4,000 | $15.19 | $60.8K | 2,729,886 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2022-12-16 | 2022-12-20 | 250 | $12.94 | $3.2K | 256,495 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-12-16 | 2022-12-20 | 1,000 | $13.01 | $13.0K | 2,725,886 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-12-09 | 2022-12-13 | 2,000 | $13.11 | $26.2K | 2,724,886 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2022-12-02 | 2022-12-06 | 250 | $13.98 | $3.5K | 256,245 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-12-02 | 2022-12-06 | 1,000 | $13.84 | $13.8K | 2,722,886 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-11-02 | 2022-11-04 | 2,000 | $8.79 | $17.6K | 2,721,886 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-10-14 | 2022-10-17 | 3,000 | $9.75 | $29.3K | 2,719,886 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-10-07 | 2022-10-11 | 2,000 | $9.72 | $19.4K | 2,716,886 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-09-30 | 2022-10-04 | 1,000 | $9.46 | $9.5K | 2,714,886 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-09-29 | 2022-10-03 | 1,000 | $9.23 | $9.2K | 2,713,886 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-06-24 | 2022-06-27 | 6,465 | $9.13 | $59.0K | 2,712,886 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-06-24 | 2022-06-27 | 22,535 | $9.13 | $205.7K | 2,706,421 | SEC↗ |
| McWilliams David | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 61,984 | — | $0 | 61,984 | SEC↗ |
| Rothe Eric | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 41,349 | — | $0 | 41,349 | SEC↗ |
| Hallock Kenneth | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 41,349 | — | $0 | 41,349 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | A Award deriv | 2022-06-22 | 2022-06-24 | 149,818 | — | $0 | 149,818 | SEC↗ |
| Patel Snehal | CEO and CFO | A Award deriv | 2022-06-22 | 2022-06-24 | 25,008 | — | $0 | 1,073,731 | SEC↗ |
| Patel Snehal | CEO and CFO | A Award deriv | 2022-06-22 | 2022-06-24 | 1,048,723 | — | $0 | 1,048,723 | SEC↗ |
| Daugherty Frank Joseph | Chief Medical Officer | A Award deriv | 2022-06-22 | 2022-06-24 | 104,890 | — | $0 | 104,890 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-06-16 | 2022-06-17 | 8,000 | $7.13 | $57.0K | 2,683,886 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-06-14 | 2022-06-15 | 12,000 | $7.91 | $94.9K | 2,675,886 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-06-10 | 2022-06-13 | 12,000 | $8.33 | $100.0K | 2,663,886 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-06-09 | 2022-06-10 | 4,500 | $10.90 | $49.0K | 1,243,453 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-06-07 | 2022-06-08 | 6,000 | $8.55 | $51.3K | 1,238,953 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-06-03 | 2022-06-06 | 9,250 | $8.35 | $77.2K | 1,232,953 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-06-02 | 2022-06-03 | 6,774 | $7.38 | $50.0K | 1,223,703 | SEC↗ |
| Daugherty Frank Joseph | Chief Medical Officer | P Buy | 2022-04-25 | 2022-04-26 | 1,000 | $16.25 | $16.3K | 90,121 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-04-21 | 2022-04-22 | 6,000 | $16.09 | $96.5K | 1,216,929 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2022-04-19 | 2022-04-20 | 500 | $16.74 | $8.4K | 255,995 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-04-19 | 2022-04-21 | 6,000 | $16.74 | $100.4K | 1,210,929 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-02-11 | 2022-02-14 | 5,500 | $19.80 | $108.9K | 1,204,929 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-02-04 | 2022-02-08 | 5,000 | $19.59 | $98.0K | 1,199,429 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2022-01-31 | 2022-02-01 | 500 | $18.47 | $9.2K | 255,495 | SEC↗ |
| Hallock Kenneth | Director | P Buy | 2022-01-21 | 2022-01-24 | 300 | $16.32 | $4.9K | 397,304 | SEC↗ |
| Thompson Jaye | VP Clinical Reg Affairs | P Buy | 2022-01-21 | 2022-01-24 | 500 | $16.33 | $8.2K | 254,995 | SEC↗ |
| Thompson Jaye | VP Clinical Reg. Affairs | P Buy | 2022-01-18 | 2022-01-19 | 500 | $18.87 | $9.4K | 254,495 | SEC↗ |
| Daugherty Frank Joseph | Chief Medical Officer | P Buy | 2022-01-13 | 2022-01-14 | 1,000 | $19.99 | $20.0K | 89,121 | SEC↗ |
| Thompson Jaye | VP Clinical Reg. Affairs | P Buy | 2022-01-13 | 2022-01-14 | 1,000 | $19.99 | $20.0K | 253,995 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-01-13 | 2022-01-18 | 1,000 | $19.99 | $20.0K | 1,194,429 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2022-01-03 | 2022-01-04 | 2,050 | $23.82 | $48.8K | 1,193,429 | SEC↗ |
| McWilliams David | Director | P Buy | 2021-12-14 | 2021-12-16 | 200 | $27.56 | $5.5K | 620,301 | SEC↗ |
| Daugherty Frank Joseph | Chief Medical Officer | P Buy | 2021-12-14 | 2021-12-16 | 1,111 | $26.99 | $30.0K | 88,121 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2021-12-14 | 2021-12-16 | 1,840 | $27.17 | $50.0K | 1,191,379 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2021-04-13 | 2021-04-14 | 2,700 | $36.98 | $99.8K | 1,189,539 | SEC↗ |
| Hallock Kenneth | Director | P Buy | 2020-11-24 | 2020-11-27 | 1,000 | $5.39 | $5.4K | 397,004 | SEC↗ |
| Daugherty Frank Joseph | Chief Medical Officer | P Buy | 2020-11-23 | 2020-11-25 | 1,000 | $5.10 | $5.1K | 87,010 | SEC↗ |
| Rothe Eric | Director | P Buy | 2020-11-20 | 2020-11-24 | 2,000 | $5.40 | $10.8K | 313,226 | SEC↗ |
| McWilliams David | Director | P Buy | 2020-11-20 | 2020-11-24 | 1,500 | $5.40 | $8.1K | 620,101 | SEC↗ |
| Hallock Kenneth | Director | P Buy | 2020-11-20 | 2020-11-24 | 1,000 | $5.37 | $5.4K | 396,004 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2020-11-19 | 2020-11-20 | 2,000 | $5.40 | $10.8K | 1,186,839 | SEC↗ |
| Patel Pankaj Amrit | 10% Owner | J Other | 2020-11-10 | 2020-11-27 | 187,266 | — | $0 | 0 | SEC↗ |
| Patel Pankaj Amrit | 10% Owner | J Other | 2020-11-10 | 2020-11-27 | 187,266 | — | $0 | 0 | SEC↗ |
| Patel Pankaj Amrit | 10% Owner | J Other | 2020-11-10 | 2020-11-27 | 187,266 | — | $0 | 0 | SEC↗ |
| Patel Kinnary | 10% Owner | M Exercise deriv | 2020-09-29 | 2020-10-09 | 7,292 | — | $0 | 0 | SEC↗ |
| Patel Kinnary | 10% Owner | M Exercise deriv | 2020-09-29 | 2020-10-09 | 76,780 | — | $0 | 0 | SEC↗ |
| Patel Kinnary | 10% Owner | M Exercise deriv | 2020-09-29 | 2020-10-09 | 45,328 | — | $0 | 0 | SEC↗ |
| Patel Kinnary | 10% Owner | J Other deriv | 2020-09-29 | 2020-10-09 | 7,292 | — | $0 | 7,292 | SEC↗ |
| Hallock Kenneth | Director | P Buy | 2020-09-29 | 2020-10-01 | 8,333 | $4.60 | $38.3K | 395,004 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2020-09-29 | 2020-10-01 | 16,667 | $4.60 | $76.7K | 1,184,839 | SEC↗ |
| Patel Kinnary | 10% Owner | M Exercise | 2020-09-29 | 2020-10-09 | 52,620 | — | $0 | 129,400 | SEC↗ |
| Patel Kinnary | 10% Owner | M Exercise | 2020-09-29 | 2020-10-09 | 76,780 | — | $0 | 76,780 | SEC↗ |
| McWilliams David | Director | M Exercise deriv | 2020-09-29 | 2020-09-30 | 6,555 | — | $0 | 0 | SEC↗ |
| McWilliams David | Director | J Other deriv | 2020-09-29 | 2020-09-30 | 1,054 | — | $0 | 1,054 | SEC↗ |
| McWilliams David | Director | M Exercise deriv | 2020-09-29 | 2020-09-30 | 1,054 | — | $0 | 0 | SEC↗ |
| McWilliams David | Director | M Exercise deriv | 2020-09-29 | 2020-09-30 | 7,663 | — | $0 | 0 | SEC↗ |
| McWilliams David | Director | M Exercise deriv | 2020-09-29 | 2020-09-30 | 152,604 | — | $0 | 0 | SEC↗ |
| McWilliams David | Director | M Exercise deriv | 2020-09-29 | 2020-09-30 | 3,746 | — | $0 | 0 | SEC↗ |
| Hallock Kenneth | Director | M Exercise deriv | 2020-09-29 | 2020-09-30 | 12,728 | — | $0 | 0 | SEC↗ |
| Hallock Kenneth | Director | M Exercise deriv | 2020-09-29 | 2020-09-30 | 79,121 | — | $0 | 0 | SEC↗ |
| Hallock Kenneth | Director | M Exercise deriv | 2020-09-29 | 2020-09-30 | 18,727 | — | $0 | 0 | SEC↗ |
| Hallock Kenneth | Director | J Other deriv | 2020-09-29 | 2020-09-30 | 12,728 | — | $0 | 12,728 | SEC↗ |
| Hallock Kenneth | Director | M Exercise deriv | 2020-09-29 | 2020-09-30 | 18,727 | — | $0 | 0 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise deriv | 2020-09-29 | 2020-09-30 | 6,929 | — | $0 | 0 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise deriv | 2020-09-29 | 2020-09-30 | 176,448 | — | $0 | 0 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise deriv | 2020-09-29 | 2020-09-30 | 1,144,529 | — | $0 | 0 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise deriv | 2020-09-29 | 2020-09-30 | 13,736 | — | $0 | 0 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise deriv | 2020-09-29 | 2020-09-30 | 76,780 | — | $0 | 0 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise deriv | 2020-09-29 | 2020-09-30 | 2,997 | — | $0 | 0 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise deriv | 2020-09-29 | 2020-09-30 | 10,394 | — | $0 | 0 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise deriv | 2020-09-29 | 2020-09-30 | 7,292 | — | $0 | 0 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise deriv | 2020-09-29 | 2020-09-30 | 14,401 | — | $0 | 0 | SEC↗ |
| Patel Snehal | CEO and CFO | J Other deriv | 2020-09-29 | 2020-09-30 | 7,292 | — | $0 | 7,292 | SEC↗ |
| Patel Snehal | CEO and CFO | J Other deriv | 2020-09-29 | 2020-09-30 | 6,929 | — | $0 | 6,929 | SEC↗ |
| Patel Snehal | CEO and CFO | J Other deriv | 2020-09-29 | 2020-09-30 | 14,401 | — | $0 | 14,401 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise deriv | 2020-09-29 | 2020-09-30 | 43,072 | — | $0 | 0 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise deriv | 2020-09-29 | 2020-09-30 | 45,328 | — | $0 | 0 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise deriv | 2020-09-29 | 2020-09-30 | 89,510 | — | $0 | 0 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise deriv | 2020-09-29 | 2020-09-30 | 33,708 | — | $0 | 0 | SEC↗ |
| McWilliams David | Director | P Buy | 2020-09-29 | 2020-09-29 | 2,608 | $5.75 | $15.0K | 446,979 | SEC↗ |
| Daugherty Frank Joseph | Chief Medical Officer | P Buy | 2020-09-29 | 2020-09-29 | 1,739 | $5.75 | $10.0K | 86,010 | SEC↗ |
| Patel Snehal | CEO and CFO | P Buy | 2020-09-29 | 2020-09-29 | 114,347 | $5.75 | $657.5K | 863,683 | SEC↗ |
| Hallock Kenneth | Director | P Buy | 2020-09-29 | 2020-09-29 | 74,782 | $5.75 | $430.0K | 257,368 | SEC↗ |
| McWilliams David | Director | M Exercise | 2020-09-29 | 2020-09-30 | 7,609 | — | $0 | 618,601 | SEC↗ |
| McWilliams David | Director | M Exercise | 2020-09-29 | 2020-09-30 | 3,746 | — | $0 | 610,992 | SEC↗ |
| McWilliams David | Director | M Exercise | 2020-09-29 | 2020-09-30 | 7,663 | — | $0 | 607,246 | SEC↗ |
| McWilliams David | Director | M Exercise | 2020-09-29 | 2020-09-30 | 152,604 | — | $0 | 599,583 | SEC↗ |
| Hallock Kenneth | Director | M Exercise | 2020-09-29 | 2020-09-30 | 79,121 | — | $0 | 386,671 | SEC↗ |
| Hallock Kenneth | Director | M Exercise | 2020-09-29 | 2020-09-30 | 18,727 | — | $0 | 276,095 | SEC↗ |
| Hallock Kenneth | Director | M Exercise | 2020-09-29 | 2020-09-30 | 18,727 | — | $0 | 294,822 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise | 2020-09-29 | 2020-09-30 | 13,736 | — | $0 | 1,053,867 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise | 2020-09-29 | 2020-09-30 | 176,448 | — | $0 | 1,040,131 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise | 2020-09-29 | 2020-09-30 | 52,620 | — | $0 | 129,400 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise | 2020-09-29 | 2020-09-30 | 76,780 | — | $0 | 76,780 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise | 2020-09-29 | 2020-09-30 | 50,001 | — | $0 | 1,408,033 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise | 2020-09-29 | 2020-09-30 | 33,708 | — | $0 | 1,358,032 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise | 2020-09-29 | 2020-09-30 | 2,997 | — | $0 | 1,324,324 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise | 2020-09-29 | 2020-09-30 | 1,144,529 | — | $0 | 1,321,327 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise | 2020-09-29 | 2020-09-30 | 103,911 | — | $0 | 1,168,172 | SEC↗ |
| Patel Snehal | CEO and CFO | M Exercise | 2020-09-29 | 2020-09-30 | 10,394 | — | $0 | 1,064,261 | SEC↗ |